- CEO
- Gerald van Wyk
- Full Time Employees
- 5,503
- Sector
- Retail trade
- Industry
- Drugstore chains
- Address
- 37 Conrad Road Johannesburg GT South Africa 1709
- IPO Date
- May 17, 2006
- Business
- AfroCentric Investment Corporation Limited AfroCentric Investment Corporation Limited (ACT.JO) is a South Africa-based Level 1 B-BBEE investment holding company listed on the Johannesburg Stock Exchange that owns and operates diversified healthcare-related enterprises across Southern Africa, providing medical scheme administration, health risk management, pharmaceutical solutions, and corporate health services to public and private sectors. The company, incorporated in 1988 and headquartered at 37 Conrad Road, Florida North, Roodepoort, operates through three primary clusters: Health Administration and Managed Care, encompassing medical scheme administration via Medscheme (South Africa's largest health risk provider serving clients like Bonitas, Fedhealth, GEMS, and Polmed), health risk management through Aid for AIDS (HIV/AIDS programs), Klinikka (musculoskeletal care), and DENIS (dental management); Pharmaceutical Solutions, including Pharmacy Direct (specialist courier pharmacy), Curasana (wholesaler), Activo Health (manufacturer and distributor), Scriptpharm Risk Management (chronic medicine management), and Forrester Pharma; and Corporate Solutions (trading as Sanlam Health), featuring EssentialMed (health insurance), AfroCentric Wellness (wellness programs), AfroCentric WorkCare (onsite healthcare), AfroCentric HealthInsure (gap cover), AfroCentric Employee Health Solutions (occupational health), and AfroCentric Integrated Health Administrators. Subsidiaries and brands such as AfroCentric Technologies (IT solutions), Afrocentric Distribution Services (marketing), and operations in Namibia, Mauritius, and Botswana extend its geographic footprint, managing over 4 million lives with nearly 6,000 employees. In recent developments, Sanlam Life Insurance Limited acquired a controlling 60% stake in AfroCentric in 2023, building on its prior 28.7% holding in subsidiary AfroCentric Healthcare Assets Proprietary Limited and integrating AfroCentric's offerings into Sanlam's ecosystem for enhanced synergies in financial products like insurance and wealth management; the company maintains strategic focus on innovation, including Hospital-at-Home, virtual care, and speech analytics, while positioning for South Africa's National Health Insurance through digital transformation and cost management.